Home / Companies / Vir Biotechnology, Inc. / 29 May 2024
Vir Biotechnology, Inc.: meeting of 29 May 2024
Votes reported on Form N-PX, item by item
316 Form N-PX filers reported votes at the Vir Biotechnology, Inc. meeting of 29 May 2024. Their records fall into 3 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
4 nominees; 65.7% of reported votes for; 99 filers withheld from or voted against at least one nominee.
889 vote records from 114 filers. 1 of the 114 filers that marked the item either way voted against management.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
467 vote records from 311 filers. 219 of the 303 filers that marked the item either way voted against management. 8 filers reported this item without a management mark.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
222 vote records from 113 filers. 2 of the 113 filers that marked the item either way voted against management.
How the largest families voted
| Family | 1. Directors | 2. Say-on-pay | 3. Auditor |
|---|---|---|---|
| Vanguard | For | For | For |
| BlackRock and iShares | Split or no vote | For | For |
| Fidelity | For | Against * | For |
| Dimensional | Split or no vote | Against * | For |
| State Street and SPDR | For | Against * | For |
| American Century | For | Against * | For |
| Franklin Templeton | For | For | For |
| Invesco | For | Against * | For |
| Equitable | Split or no vote | For | For |
| Charles Schwab | Split or no vote | Against * | For |
| Nuveen and TIAA | For | Against * | For |
| ProShares and ProFunds | For | Against * | For |
| John Hancock and Manulife | For | Against * | For |
| Morgan Stanley, Eaton Vance and Calvert | For | Against * | For |
| J.P. Morgan | For | Against * | For |
| Goldman Sachs | For | Against * | For |
| WisdomTree | Split or no vote | Split or no vote | Split or no vote |
| PGIM and Prudential | Split or no vote | Against * | For |
| Jackson National funds | For | Against * | For |
| Northern Trust and FlexShares | Split or no vote | For | For |
| SEI | Split or no vote | Against * | For |
| T. Rowe Price | Split or no vote | Against * | For |
| Thrivent | For | Against * | For |
| Lincoln Financial | Split or no vote | Against * | For |
| Voya | Split or no vote | Against * | For |
| Russell Investments | For | Against * | For |
| Nationwide | For | Against * | For |
| Victory Capital | For | Against * | For |
| Brighthouse Funds | For | Against * | For |
| Guggenheim and Rydex | For | Against * | For |
| Columbia Threadneedle | For | Against * | For |
| BNY Mellon | For | Against * | For |
| Principal | For | Against * | For |
| Capital Group and American Funds | For | Against * | For |
| Pacific Life funds | Split or no vote | For | For |
| Global X | Split or no vote | Against * | For |
| Federated Hermes | Split or no vote | For | For |
| AllianceBernstein | No report | Against * | No report |
| DWS | Split or no vote | Against * | For |
| MassMutual | No report | For | No report |
| Janus Henderson | No report | Against * | No report |
| Neuberger Berman | No report | Against * | No report |
| Natixis and Loomis Sayles | No report | Against * | No report |
| Baird | No report | Against * | No report |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Vir Biotechnology, Inc. meeting?
316 Form N-PX filers reported votes at the meeting of 29 May 2024. On say-on-pay, 219 of 303 voted against management (72.3%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Vir Biotechnology, Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Vir Biotechnology, Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Vir Biotechnology, Inc. with a meeting date within three days of 29 May 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.